Jing Tian

Jing Tian

Auto-generated profile, based on publicly available information

Jing Tian

Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

1 January 2020 in Osteoarthritis and Cartilage
Verified
Journal Article
Closed access
FPFeng Pan
Feng Pan
JTJ. Tian
J. Tian
FCFlavia M. Cicuttini
Flavia M. Cicuttini
GJG. Jones
G. Jones

1 December 2018 in Osteoarthritis and Cartilage
Verified
Journal Article
Closed access
FPFeng Pan
Feng Pan
JTJ. Tian
J. Tian
DAD. Aitken
D. Aitken
FCFlavia M. Cicuttini
Flavia M. Cicuttini
GJG. Jones
G. Jones

1 September 2018 in Fertility and Sterility
Verified
Journal Article
Closed access
YHYe He
Ye He
JTJing Tian
Jing Tian
WOWendy H. Oddy
Wendy H. Oddy
TDTerence Dwyer
Terence Dwyer
AVAlison J. Venn
Alison J. Venn

27 August 2015 in Quality of Life Research
Verified
Journal Article
Closed access
PDF file
JTJing Tian
Jing Tian
AVAlison J. Venn
Alison J. Venn
LBLeigh Blizzard
Leigh Blizzard
GPGeorge C. Patton
George C. Patton
TDTerry Dwyer
Terry Dwyer
SGSeana Gall
Seana Gall

30 November 2012 in Asian Pacific Journal of Cancer Prevention
Verified
Journal Article
Open access
PDF file
FPFeng Pan
Feng Pan
JTJing Tian
Jing Tian
CJChu-Shu Ji
Chu-Shu Ji
YHYi-Fu He
Yi-Fu He
XHXing-Hua Han
Xing-Hua Han
BHBing Hu
Bing Hu
Association of TNF-α-308 and -238 Polymorphisms with Risk of Cervical Cancer: A Meta-analysis Cervical cancer;genetic polymorphisms;TNF-${\alpha}$;susceptibility;meta-analysis; Published data on the associations between tumor necrosis factor-alpha (TNF-${\alpha}$) promoter -308G>A and -238G>A polymorphisms and cervical cancer risk are inconclusive. To derive a more precise estimation of the relationship, a meta-analysis was performed. Data were collected from MEDLINE and PubMed databases. Crude odds ratios (ORs) with 95% confidence intervals (CIs) were calculated in a fixed/random effect model. 13 separate studies including 3294 cases and 3468 controls were involved in the meta-analysis. We found no association between TNF-${\alpha}$-308G>A polymorphism and cervical cancer in overall population. In subgroup analysis, significantly elevated risks were found in Caucasian population (A vs. G: OR = 1.43, 95% CI = 1.00-2.03; AA vs. GG: OR = 2.09, 95% CI = 1.34-3.25; Recessive model: OR = 2.09, 95% CI = 1.35-3.25) and African population (GA vs. GG: OR = 1.53, 95% CI = 1.02-2.30). An association of TNF-${\alpha}$-238G>A polymorphism with cervical cancer was found (A vs. G: OR = 0.61, 95% CI = 0.47-0.78; GA vs. GG: OR = 0.59, 95% CI = 0.45-0.77; Dominant model: OR = 0.59, 95% CI = 0.46-0.77). When stratified by ethnicity, similar association was observed in Caucasian population (A vs. G: OR = 0.62, 95% CI = 0.46-0.84; GA vs. GG: OR = 0.59, 95% CI = 0.43-0.82; Dominant model: OR = 0.60, 95% CI = 0.44-0.83). In summary, this meta-analysis suggests that TNF-${\alpha}$-238A allele significantly decreased the cervical cancer risk, and the TNF-${\alpha}$-308G>A polymorphism is associated with the susceptibility to cervical cancer in Caucasian and African population.